LexDanaLexDanabeta
Inventor

BINDU VARGHESE

Inventor
US

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
A01KAnimal husbandry8%
C12NMicroorganisms or enzymes8%
C12YEnzymes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
12,161,097Non-human animals having a humanized signal-regulatory protein gene202412,054,557Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer202411,434,300Methods and antibody compositions for tumor treatment2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to REGENERON PHARMA (3)· patent assignee history
2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REGENERON PHARMA32022–2024
Locations
LocationPatentsSpan
US32022–2024